A Win For Genprex, Inc.
Wed, Oct 15, 2025 at 08:02 PM
Genprex, Inc. (GNPX:NASDAQ) jumped higher at $0.84, a gain of 232.7%. On Wed, Oct 15, 2025, GNPX:NASDAQ hit a New 2-Week High of $0.84. The stock appeared on our News Catalysts scanner on Tue, Oct 14, 2025 at 09:53 AM in the 'PATNERSHIP' category. From Wed, Oct 01, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Oct 15, 2025 at $1.1 with a volume of 917M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 325%
- Genprex, Inc. (GNPX:NASDAQ), 232.67%
- Australian Oilseeds Holdings Limited (COOT:NASDAQ), 173.58%
- Omeros Corporation (OMER:NASDAQ), 154.15%
- Pinnacle Food Group Limited (PFAI:NASDAQ), 139.27%
- Theriva Biologics, Inc. (TOVX:NYSEMKT), 92.09%
- TrueCar, Inc. (TRUE:NASDAQ), 62.16%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 53.76%
- Veritone, Inc. (VERI:NASDAQ), 53.66%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 48.91%